Literature DB >> 22194142

First report of incidence of adult myelodysplastic syndrome in China.

Wei Wang, Hong Wang, Xiao-Qin Wang, Guo-Wei Lin.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22194142     DOI： 10.1007/s00277-011-1389-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

1.  A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in Lebanon.

Authors:  Zaher K Otrock; Nabil Chamseddine; Ziad M Salem; Tarek Wehbe; Mouna Al-Ayoubi; Moussa Dhaini; Joseph Kattan; Walid Mokaddem; Therese Abi Nasr; Oussama Jradi; Fadi S Farhat; Mahmoud Wehbe; Mohammad H Haidar; Mohamed A Kharfan-Dabaja; Nizar Bitar; Mirna El Hajj; Adel M Kadri; Francois G Kamar; Hanan Yassine; Hassan Khodr; Ali T Taher; Noha Hakime; Rami Ar Mahfouz; Wassim Serhal; Ali Bazarbachi; Hussein Z Farhat
Journal:  Am J Blood Res       Date:  2015-12-25

2.  Asia-inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial.

Authors:  Xiaofei Zhou; Sharon Friedlander; Erik Kupperman; Farhad Sedarati; Shingo Kuroda; Zhaowei Hua; Ying Yuan; Yuka Yamamoto; Douglas V Faller; Kazue Haikawa; Katsuhiko Nakai; Sharon Bowen; Yi Dai; Karthik Venkatakrishnan
Journal:  Clin Transl Sci       Date:  2021-02-02       Impact factor: 4.689

3.  Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes.

Authors:  H Xiong; X Y Yang; J Han; Q Wang; Z L Zou
Journal:  Braz J Med Biol Res       Date:  2015-01-20       Impact factor: 2.590

4.  Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes.

Authors:  Nehakumari Maurya; Purvi Mohanty; Somprakash Dhangar; Purvi Panchal; Farah Jijina; S Leo Prince Mathan; Chandrakala Shanmukhaiah; Manisha Madkaikar; Babu Rao Vundinti
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

5.  Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study.

Authors:  Yuxin Wang; Yao Sun; Jing Xie; Jiangwei Hu; Na Liu; Jianlin Chen; Botao Li; Sanchun Lan; Jingwen Niu; Lei Wang; Zhuoqing Qiao; Yu Zhang; Jing Ren; Bin Zhang; Liren Qian; Yehui Tan; Liping Dou; Yuhang Li; Liangding Hu
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

6.  Incidence of myelodysplastic syndrome in Japan.

Authors:  Dai Chihara; Hidemi Ito; Kota Katanoda; Akiko Shibata; Tomohiro Matsuda; Tomotaka Sobue; Keitaro Matsuo
Journal:  J Epidemiol       Date:  2014-08-02       Impact factor: 3.211
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.